CA2030056A1 - 5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepines et leur utilisation pour la prevention ou le traitement de l'infection par le hiv - Google Patents

5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepines et leur utilisation pour la prevention ou le traitement de l'infection par le hiv

Info

Publication number
CA2030056A1
CA2030056A1 CA2030056A CA2030056A CA2030056A1 CA 2030056 A1 CA2030056 A1 CA 2030056A1 CA 2030056 A CA2030056 A CA 2030056A CA 2030056 A CA2030056 A CA 2030056A CA 2030056 A1 CA2030056 A1 CA 2030056A1
Authority
CA
Canada
Prior art keywords
dipyrido
diazepines
dihydro
prevention
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2030056A
Other languages
English (en)
Other versions
CA2030056C (fr
Inventor
Karl D. Hargrave
Gunther Schmidt
Engel Wolfhard
Gunter Trummlitz
Wolfgang Eberlein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Boehringer Ingelheim Pharmaceuticals Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27412005&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2030056(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of CA2030056A1 publication Critical patent/CA2030056A1/fr
Application granted granted Critical
Publication of CA2030056C publication Critical patent/CA2030056C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA002030056A 1989-11-17 1990-11-15 5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepines et leur utilisation pour la prevention ou le traitement de l'infection par le hiv Expired - Lifetime CA2030056C (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US43892389A 1989-11-17 1989-11-17
US07/438,923 1989-11-17
US57900190A 1990-09-06 1990-09-06
US07/579,001 1990-09-06
US60039090A 1990-10-19 1990-10-19
US07/600,390 1990-10-19

Publications (2)

Publication Number Publication Date
CA2030056A1 true CA2030056A1 (fr) 1991-05-18
CA2030056C CA2030056C (fr) 1995-10-17

Family

ID=27412005

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002030056A Expired - Lifetime CA2030056C (fr) 1989-11-17 1990-11-15 5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepines et leur utilisation pour la prevention ou le traitement de l'infection par le hiv

Country Status (21)

Country Link
EP (1) EP0429987B1 (fr)
AP (1) AP179A (fr)
AT (1) ATE177744T1 (fr)
AU (1) AU630251B2 (fr)
CA (1) CA2030056C (fr)
DE (2) DE69033003T2 (fr)
DK (1) DK0429987T3 (fr)
ES (1) ES2130114T3 (fr)
FI (1) FI94529C (fr)
GR (1) GR3030100T3 (fr)
HK (1) HK1011025A1 (fr)
IE (1) IE904141A1 (fr)
IL (1) IL96367A (fr)
LU (1) LU90393I2 (fr)
NL (1) NL990022I2 (fr)
NO (2) NO175478C (fr)
NZ (1) NZ236105A (fr)
OA (1) OA09852A (fr)
PT (1) PT95919B (fr)
RU (1) RU2040527C1 (fr)
UA (1) UA34420C2 (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366972A (en) * 1989-04-20 1994-11-22 Boehringer Ingelheim Pharmaceuticals, Inc. 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection
GB9109557D0 (en) * 1991-05-02 1991-06-26 Wellcome Found Chemical compounds
WO1992022531A1 (fr) * 1991-06-11 1992-12-23 Boehringer Ingelheim Pharmaceuticals, Inc. Procede de preparation de 3-amino-2-chloro-4-alkylpyridines
US5200522A (en) * 1991-06-11 1993-04-06 Boehringer Ingelheim Pharmaceuticals, Inc. Method for preparing 3-amino-2-chloro-4-alkylpyridines
DE4138908A1 (de) * 1991-11-27 1993-06-03 Bayer Ag 6-thiono-dibenz(b,e)azepine
DE4138853A1 (de) * 1991-11-27 1993-06-03 Bayer Ag 5,6-dihydro-dibenz(b,e)azepin-6,11-dion-11- oxime
DE69320759T2 (de) * 1992-11-18 1999-03-25 Boehringer Ingelheim Pharma Verbesserte Methode zur Herstellung von 4-Alkyl-3-Amino-2-Chlor-Pyridinen
AU5883794A (en) * 1993-01-20 1994-08-15 A. Menarini Industrie Farmaceutiche Riunite S.R.L. Diazepin derivatives and antiviral compositions
DE4333697A1 (de) * 1993-10-02 1995-04-06 Merck Patent Gmbh Verfahren zur Herstellung von 3-Aminopyridinen aus 3-Nitropyridinen
DE4403311C1 (de) * 1994-02-03 1995-04-20 Boehringer Ingelheim Kg Verfahren zur Herstellung von Nevirapine (11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4-diazepin]-6-on)
CA2183571A1 (fr) * 1994-02-18 1995-08-24 Karl D. Hargrave 2-heteroaryl-5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4] diazepines et leur utilisation dans la prevention ou le traitement de l'infection a vih
US5917033A (en) * 1995-10-31 1999-06-29 University Of Medicine & Dentistry Of New Jersey Structure based design of inhibitors of HIV-1 reverse transcriptase
US5747488A (en) * 1996-01-30 1998-05-05 Boehringer Ingelheim Pharmaceuticals, Inc. 2-aryl-5,11-dihydro-6H-dipyrido 3,2-B:2',3'-E! 1, 4!diazepines and their use in the treatment of HIV infection
ATE326971T1 (de) * 1997-08-25 2006-06-15 Boehringer Ingelheim Pharma Pharmazeutische suspension mit nevirapine hemihydrat
DE10023492A1 (de) * 2000-05-09 2001-11-22 Schering Ag Aza- und Polyazanthranylamide und deren Verwendung als Arzneimittel
US6995162B2 (en) 2001-01-12 2006-02-07 Amgen Inc. Substituted alkylamine derivatives and methods of use
US7102009B2 (en) 2001-01-12 2006-09-05 Amgen Inc. Substituted amine derivatives and methods of use
US6878714B2 (en) 2001-01-12 2005-04-12 Amgen Inc. Substituted alkylamine derivatives and methods of use
US7105682B2 (en) 2001-01-12 2006-09-12 Amgen Inc. Substituted amine derivatives and methods of use
US7307088B2 (en) 2002-07-09 2007-12-11 Amgen Inc. Substituted anthranilic amide derivatives and methods of use
EP1768674A1 (fr) 2004-07-16 2007-04-04 ProteoSys AG Antagonistes muscariniques avec activite modulatrice parp et sir en tant qu'agents cytoprotecteurs
US8247556B2 (en) 2005-10-21 2012-08-21 Amgen Inc. Method for preparing 6-substituted-7-aza-indoles
CN101784263B (zh) 2007-06-08 2012-11-07 贝林格尔.英格海姆国际有限公司 奈韦拉平的延长释放制剂
WO2010081823A1 (fr) 2009-01-13 2010-07-22 Proteosys Ag Pirenzépine au titre d'agent otoprotecteur
WO2016083276A1 (fr) 2014-11-25 2016-06-02 Bayer Pharma Aktiengesellschaft Dérivés de pyridobenzodiazepinone substitués et leur utilisation
EP3153157A1 (fr) 2015-10-09 2017-04-12 Teva Pharmaceutical Works Private Limited Company Composition pharmaceutique à libération prolongée de névirapine
CN107382848A (zh) * 2017-07-15 2017-11-24 河北蓝泰化工科技有限公司 一种烟酰胺化合物及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA554134A (fr) * 1958-03-11 Hoffmann Karl Composes thia-aza-cycloheptadiene et procede pour leur fabrication
CA783570A (en) * 1968-04-23 Schmidt Gunther 5,6-dihydro-6-oxo-11h-pyrido (2,3-b) (1,4)-benzodiazepines
CA658624A (en) * 1963-02-26 Schmutz Jean Diazepine derivatives
DE3643666A1 (de) * 1986-12-20 1988-06-30 Thomae Gmbh Dr K Neue kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3726908A1 (de) * 1987-08-13 1989-02-23 Thomae Gmbh Dr K Neue kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3735895A1 (de) * 1987-10-23 1989-05-03 Thomae Gmbh Dr K Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE69002079T2 (de) * 1989-04-20 1993-11-18 Boehringer Ingelheim Pharma 5,11-Dihydro-6H-dipyrido [3,2-b:2',3'-e]diazepin-6-one und deren Verwendung in der Vorbeugung und Behandlung von AIDS.
ATE161535T1 (de) * 1989-04-20 1998-01-15 Boehringer Ingelheim Pharma 6,11-dihydro-5h-pyrido(2,3-b)(1,5)benzodiazepin 5-one und thione und ihre verwendung für die vorbeugung oder behandlung von aids
ATE103918T1 (de) * 1989-06-28 1994-04-15 Boehringer Ingelheim Pharma 5,11-dihydro-6h-dipyrido(3,2-b:2',3'e>(1,4>diazepin-6-one und -thione und ihre verwendung bei der aids-vorbeugung oder behandlung.

Also Published As

Publication number Publication date
EP0429987A3 (en) 1992-01-22
NL990022I1 (nl) 1999-10-01
PT95919B (pt) 1998-01-30
RU2040527C1 (ru) 1995-07-25
NO175478B (no) 1994-07-11
IL96367A (en) 1997-02-18
AP9000224A0 (en) 1991-01-31
FI905674A0 (fi) 1990-11-16
FI94529B (fi) 1995-06-15
NZ236105A (en) 1994-04-27
AU630251B2 (en) 1992-10-22
GR3030100T3 (en) 1999-07-30
NL990022I2 (nl) 2007-11-01
EP0429987B1 (fr) 1999-03-17
DE69033003T2 (de) 1999-09-16
NO904986D0 (no) 1990-11-16
ES2130114T3 (es) 1999-07-01
PT95919A (pt) 1991-09-13
FI905674A (fi) 1991-05-18
ATE177744T1 (de) 1999-04-15
NO1999013I1 (no) 1999-06-29
DE69033003D1 (de) 1999-04-22
NO904986L (no) 1991-05-21
EP0429987A2 (fr) 1991-06-05
IE904141A1 (en) 1991-05-22
HK1011025A1 (en) 1999-07-02
CA2030056C (fr) 1995-10-17
FI94529C (fi) 1995-09-25
DK0429987T3 (da) 1999-10-11
AU6673290A (en) 1991-05-23
OA09852A (en) 1994-08-15
DE19975051I2 (de) 2004-05-06
UA34420C2 (uk) 2001-03-15
LU90393I2 (fr) 1999-06-30
AP179A (en) 1992-04-30
NO175478C (no) 1994-10-19

Similar Documents

Publication Publication Date Title
CA2030056A1 (fr) 5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepines et leur utilisation pour la prevention ou le traitement de l'infection par le hiv
AU649605B2 (en) Retinal, derivatives and their therapeutic use
CA2019812A1 (fr) Nouveau 5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-ones et leur utilisation dans la prevention et le traitement du sida
CA2041113A1 (fr) Derives de la thienobenzodiazepine et leur utilisation comme produits pharmaceutiques
HU9502726D0 (en) [1,2,4]triazolo[4,3-a]qunoxaline derivatives, their preparation and use
CA2014885A1 (fr) 6,11-dihydro-5h-pyrido[2,3-b] [1,5] benzodiazepin-5-ones et thiones et leur utilisation dans la prevention et le traitement du sida
TW327171B (en) 2-heteroaryl-5 for prevention or treatment of HIV infection
EP0791594A3 (fr) 2-Aryl-5,11-dihydro-6H-dipyrido 3,2-b:2',3'-e 1,4 diazepines et leur utilisation pour le traitement de l'infection par le HlV
GR3021428T3 (en) Pyridobenzodiazepines, dipyrido [3,2-b:2',3'-e] [1,4]diazepines and their use in the prevention or treatment of HIV infection
CA2014884A1 (fr) 5,11-dihydro-6h-pyrido[2,3-b] [1,4] benzodiazepin-6-ones et-thiones et leur utilisation dans la prevention ou le traitement du sida
CA2187146A1 (fr) 8-arylalkyl- et 8-arylheteroalkyl-5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e]-[1,4]-diazepines et leur utilisation pour la prevention ou le traitement des infections par le vih
ZA909246B (en) 5,11-dihydro-6h-dipyrido(3,2-b:2',3'-e)(1,4)diazepines and their use in the prevention or treatment of hiv infection
ZA951318B (en) 2-heteroaryl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4] diazepines and their use in the prevention or treatment of HIV infection
CA2024071A1 (fr) Pyrido[2,3-b][1,5]benzoxazepine (et -thiazepine)-5(6h)-ones et -thiones et leur utilisation pour la prevention et le traitement des infections a hiv
EP0415304A3 (en) Dipyrido(3,2-b:2',3'-e)(1,4)oxazepin (and thiazepin)-6(5h)-ones and -thiones and their use in the prevention or treatment of aids
ZA955942B (en) 4-hydroxy-3-phenylindeno[1,2-b]pyridin-2(1H)-one derivatives their preparation and the medicaments containing them
PH31562A (en) Pyrido (2,3-B) (1,5) benzoxazepin (and thiazepin)-5(6H)-ones and thiones and their use on the treatment of hiv infection.
AU8061394A (en) 1,3,8,10 tetrasubstituted derivatives of 4,5,6,7-tetrathiocino-(1,2-b:3,4-b')-diimidazolyl-2,9-dithio ne, their preparation and their use as antitumor agent
MX9700716A (es) 2-aril-5,11-dihidro-6h-dipirido[3,2-b:2',3'-e][1,4] diazepinas y su uso en el tratamiento de la infeccion por vih.
CA2162468A1 (fr) Utilisation de nona- et de decapeptides dans la preparation d'un medicament pour le traitement du sida
AU646096C (en) Method for the preparation of 5,11-dihydro-6H-dipyrido (3,2-b:2',3'-e)(1,4)diazepines
AU8592491A (en) Method for the preparation of 5,11-dihydro-6h-dipyrido (3,2-b:2',3'-e)(1,4)diazepines

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry